Will Apple devices’ passive atrial fibrillation detection prevent strokes? Estimating the proportion of high-risk actionable patients with real-world user data
Open Access
- 22 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 29 (6) , 1040-1049
Abstract
Utilizing integrated electronic health record (EHR) and consumer-grade wearable device data, we sought to provide real-world estimates for the proportion of wearers that would likely benefit from anticoagulation if an atrial fibrillation (AFib) diagnosis was made based on wearable device data. This study utilized EHR and Apple Watch data from an observational cohort of 1802 patients at Cedars-Sinai Medical Center who linked devices to the EHR between April 25, 2015 and November 16, 2018. Using these data, we estimated the number of high-risk patients who would be actionable for anticoagulation based on (1) medical history, (2) Apple Watch wear patterns, and (3) AFib risk, as determined by an existing validated model. Based on the characteristics of this cohort, a mean of 0.25% (n = 4.58, 95% CI, 2.0–8.0) of patients would be candidates for new anticoagulation based on AFib identified by their Apple Watch. Using EHR data alone, we find that only approximately 36% of the 1802 patients (n = 665.93, 95% CI, 626.0–706.0) would have anticoagulation recommended even after a new AFib diagnosis. These data suggest that there is limited benefit to detect and treat AFib with anticoagulation among this cohort, but that accessing clinical and demographic data from the EHR could help target devices to the patients with the highest potential for benefit. Future research may analyze this relationship at other sites and among other wearable users, including among those who have not linked devices to their EHR.Keywords
Funding Information
- Cedars-Sinai Precision Health
This publication has 21 references indexed in Scilit:
- Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial FibrillationJAMA, 2018
- Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial FibrillationJACC, 2017
- Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial FibrillationJAMA, 2017
- A Large-Scale Initiative Inviting Patients to Share Personal Fitness Tracker Data with Their Providers: Initial ResultsPLOS ONE, 2016
- Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic WhitesThe American Journal of Cardiology, 2016
- Contraindications to Anticoagulation Therapy and Eligibility for Novel Anticoagulants in Older Patients with Atrial FibrillationCardiovascular Therapeutics, 2015
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 CountriesCirculation, 2014
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF ConsortiumJournal of the American Heart Association, 2013
- Disparities in Enrollment and Use of an Electronic Patient PortalJournal of General Internal Medicine, 2011
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991